Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

529.70INR
1 Sep 2014
Price Change (% chg)

Rs15.40 (+2.99%)
Prev Close
Rs514.30
Open
Rs519.80
Day's High
Rs531.95
Day's Low
Rs515.00
Volume
186,517
Avg. Vol
198,813
52-wk High
Rs531.95
52-wk Low
Rs366.70

CIPL.BO

Chart for CIPL.BO

About

Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31, 2012 (fiscal 2012), it introduced a number of new drugs and formulations, such as Adgain (vital nutritional supplement for hair loss); Capnea (caffeine citrate injection and oral solution) for apnoea of prematurity in infants; Caspogin (caspofungin... (more)

Overall

Beta: 0.51
Market Cap (Mil.): Rs412,862.19
Shares Outstanding (Mil.): 802.92
Dividend: 2.00
Yield (%): 0.39

Financials

  CIPL.BO Industry Sector
P/E (TTM): 29.75 32.30 33.23
EPS (TTM): 17.28 -- --
ROI: -- 17.96 17.21
ROE: -- 18.60 18.01
Search Stocks

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.

01 Sep 2014

Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI - Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.

01 Sep 2014

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI, Sept 1 - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.

01 Sep 2014

Cipla gains after April-June margins expand sequentially

Reuters Market Eye - Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.

18 Aug 2014

Indian shares hit record high on Modi hopes, wholesale inflation

* BSE index gains 1.1 pct; NSE ends 1.06 pct higher * Tata Motors' DVR shares up on potential index inclusion report * Cipla gains after April-June margins expand sequentially By Abhishek Vishnoi MUMBAI, Aug 18 - Indian shares rose over 1 percent on Monday to a record high as blue-chips such as ICICI Bank surged after Prime Minister Narendra Modi vowed to fire up the bureaucracy to deliver results, while easing wholesale inflation also helped. The broader NSE inde

18 Aug 2014

MARKET EYE -India's Cipla gains after April-June margins expand sequentially

* Shares in drugmaker Cipla gain 1.4 percent after April-June operating margins beat some estimates. * Margins expand sequentially by nearly 4 percentage points to 20 percent. * Investors say management maintained revenue guidance of mid-teens growth and 20 percent margins in FY15 in a conference call. * Strong growth in India and better product mix will further aid margins, fund managers add. (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

18 Aug 2014

Cipla Q1 net profit lags estimates as higher costs hurt

MUMBAI - Cipla Ltd, India's fourth-largest drugmaker by sales, on Thursday reported first-quarter profit that was much lower than expectations due to higher employee costs and other expenses.

14 Aug 2014

India's Cipla Q1 net profit lags estimates as higher costs hurt

MUMBAI, Aug 14 - Cipla Ltd, India's fourth-largest drugmaker by sales, on Thursday reported first-quarter profit that was much lower than expectations due to higher employee costs and other expenses.

14 Aug 2014

Cipla Medpro says awarded South Africa drug tender

JOHANNESBURG, Aug 7 - South Africa has awarded Cipla Medpro a 280 million rand($26 million) share of a government tender to supply therapeutic drugs from Aug. 1, the company said on Thursday.

07 Aug 2014

UPDATE 1-S.African govt awards $33 mln respiratory contract to Cipla

CAPE TOWN, June 26 - South Africa has awarded Cipla Medpro a 345 million rand ($32.6 million) share in the national respiratory tender as Africa's most advanced economy seeks to cut high asthma mortality rates, the company said on Thursday.

26 Jun 2014

Earnings vs. Estimates

Search Stocks